This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Xiangdong Zhao: Innovator in Liver Preservation Solutions
Introduction
Xiangdong Zhao is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of liver preservation, particularly through his innovative patent that enhances the viability of liver transplants. His work is crucial for improving outcomes in liver transplantation procedures.
Latest Patents
Xiangdong Zhao holds a patent titled "Method for preserving liver in a solution comprising dibutyryl cAMP." This invention provides a liver preservation solution that contains trehalose and dibutyryl-cAMP. The solution is designed to reduce the toxicity associated with nitroglycerin, which is often observed during liver preservation. The optimal content of nitroglycerin in this preservation solution is preferably lower than 0.44 mM. This advancement allows for liver transplantation to be performed with a higher engrafted rate, thereby improving patient outcomes.
Career Highlights
Xiangdong Zhao is currently employed at Otsuka Pharmaceutical Factory, Inc., where he continues to develop innovative solutions in the pharmaceutical field. His work focuses on enhancing the preservation of organs for transplantation, which is a critical area in medical science.
Collaborations
Xiangdong has collaborated with esteemed colleagues such as Takaaki Koshiba and Hiromi Wada. Their combined expertise contributes to the advancement of research and development in liver preservation techniques.
Conclusion
Xiangdong Zhao's contributions to liver preservation technology represent a significant advancement in the field of organ transplantation. His innovative solutions are poised to improve the success rates of liver transplants, ultimately benefiting patients in need of this life-saving procedure.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
